Health Condition 1: F341- Dysthymic disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All the sexes of the age group 18-65 years irrespective of their socio-economic status will be included. Participants must have a clinical diagnosis of Dysthymic Disorder based on standardized ICD 11 (International Classification of Diseases) diagnostic criteria. Participants who have a Cornell Dysthymia Rating Scale (CDRS) score between 20 and 59, indicating mild to moderate dysthymia will be included.
Exclusion criteria
Exclusion criteria: 1.Participants with other severe psychiatric disorders (bipolar disorder schizophrenia) will be excluded from the study. 2.Participants who show evidence of high suicide risk as assessed by the Suicide Behaviours Questionnaire Revised (SBQ-R) will be excluded from the study. Specifically Individuals scoring at or above the established cutoff score for their population (more than or equal to 7 for the general population, more than or equal to for psychiatric inpatients) indicating significant suicidal ideation or behaviour. 3. Individuals with substance abuse issues will be excluded. 4. Medical or neurological conditions that may influence mood symptoms or interfere with the assessment or treatment of dysthymia such as severe cardiovascular disease, endocrine disorders (hypothyroidism) or neurological illnesses ( Parkinson s disease multiple sclerosis) will be excluded. 5. pregnant women and lactating mother will be excluded from the study. 6. Patients who are under any modern psychiatric medication. 7.Patients who develop symptoms of psychosis in between the study will be referred to a psychiatrist as per the patient s requirement. 8.Patients with organic mental disease will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cornell Dysthymia Rating Scale (CDRS) scoreTimepoint: assess at baseline and at the end of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Naranjo Criteria (MONARCH) score.Timepoint: At the end of treatment (3rd month) | — |
Countries
India
Contacts
National Institute of Homoeopathy, Delhi.